Anixa Biosciences ANIX
NASDAQ ANIX
$2.99 +0.21 (+7.55%)
At close: Oct 23, 2026 · 4:00 PM EDT

Anixa Biosciences (ANIX) Gains from Investment Securities (2010 - 2014)

Updated

Analysis

Anixa Biosciences (ANIX) Gains from Investment Securities (2010 - 2014) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,137.66 Bn 1,106.24 Bn 19.71 Bn
2 Johnson & Johnson 636.13 Bn 556.00 Bn 17.30 Bn
3 AbbVie 505.28 Bn 478.39 Bn 12.70 Bn
4 Merck 358.10 Bn 312.48 Bn 12.21 Bn
5 Novartis Ag 292.59 Bn 256.58 Bn 11.24 Bn
6 Astrazeneca 265.81 Bn 239.50 Bn 12.86 Bn
7 Amgen 237.53 Bn 192.93 Bn 7.24 Bn
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn
9 Pfizer 171.17 Bn 117.82 Bn 10.94 Bn
10 Anixa Biosciences 101.52 Mn 87.66 Mn -
Historic Data

Historic Data

Download Data
DateValue
Oct 31, 2014 867,759.00
Jul 31, 2014 850,000.00
Apr 30, 2014 -990,704.00
Jan 31, 2014 -1.32 Mn
Oct 31, 2013 -1.50 Mn
Jul 31, 2013 105,189.00
Apr 30, 2013 210,000.00
Jan 31, 2013 7,166.00
Jul 31, 2011 -60,338.00
Apr 30, 2011 26,168.00
Jan 31, 2011 4,001.00
Oct 31, 2010 -655.00
API Access

Anixa Biosciences Gains from Investment Securities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=gains-from-investment-securities&ticker=ANIX&period=max&api_key=YOUR_API_KEY